Summary & Overview
CPT 78414: Cardiac Perfusion Imaging with Pharmacologic Stress Assessment
CPT code 78414 designates a cardiac perfusion imaging procedure that measures blood flow in the central cardiovascular system and may include use of a pharmacologic stressor to assess changes in ejection fraction. This modality is clinically important for diagnosing ischemia, assessing ventricular function, and guiding management of patients with suspected or known coronary artery disease. Nationally, accurate coding for this service affects clinical tracking, quality measurement, and appropriate facility reimbursement for advanced cardiac imaging.
Key payers covered in the analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical indications and typical sites of service, plus benchmarking expectations where available. The publication outlines coding context, common billing modifiers, and considerations for claims processing and coverage determinations.
The report provides reference benchmarks and policy summaries relevant to payers and providers, clarifies clinical context for CPT code 78414, and identifies gaps where input data is not provided. Intended readers include hospital billing managers, cardiovascular imaging specialists, and payer policy teams seeking a concise national-level briefing on coding and utilization implications for this cardiac perfusion procedure.
Billing Code Overview
CPT code 78414 describes a diagnostic cardiac imaging procedure in which a provider uses an appropriate device or probe to assess blood flow in the central cardiovascular system. The procedure may include administration of a pharmacological agent to stimulate blood flow and measure changes in ejection fraction.
-
Service type: Cardiac perfusion imaging / myocardial blood flow assessment
-
Typical site of service: Hospital outpatient department, outpatient imaging center, or cardiac catheterization/imaging suite
Clinical & Coding Specifications
Clinical Context
A 68-year-old patient with a history of ischemic cardiomyopathy and worsening exertional dyspnea is referred for an assessment of left ventricular function. The cardiology team schedules a radionuclide ventriculography using an appropriate probe to quantify ejection fraction at rest and after pharmacologic stress to evaluate contractile reserve. The workflow includes pre-procedure consent, review of medications (holding interfering agents per local protocol), intravenous placement for radiotracer or pharmacologic agent administration, acquisition of baseline images to determine resting ejection fraction, administration of a vasodilator or inotrope to provoke coronary flow or contractility, repeat imaging to measure peak-change ejection fraction, and post-procedure monitoring for hemodynamic stability. Results are interpreted by a cardiologist or nuclear medicine physician and incorporated into the patient’s heart failure management plan.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when only the physician interpretation/report is billed separately from the technical imaging component. |
TC | Technical component |